Altimmune Announces Second Quarter 2022 Financial Results and Provides a Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Altimmune, Inc. (ALT) Tops Q2 EPS by 8c
August 11, 2022 7:04 AM EDTAltimmune, Inc. (NASDAQ: ALT) reported Q2 EPS of ($0.42), $0.08 better than the analyst estimate of ($0.50). Revenue for the quarter came in at $8 thousand versus the consensus estimate of $866.67 thousand.
For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.
... More